Patients living in rural areas of North America may not receive guideline-concordant care because of diminished or accelerated access to surgery and lack of access to the full spectrum of treatment ...
Cost-effectiveness of biomarker-directed bevacizumab for first-line therapy of persons with metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results